SCHEMBL6556007

SCHEMBL6556007

CNC(=O)c1n[nH]c2ccc(S(=O)(=O)Oc3ccc(Cl)c(Cl)c3)cc12.CS(=O)(=O)c1ccccc1S(=O)(=O)O.NC(=O)c1n[nH]c2ccc(S(=O)(=O)Oc3ccc(Cl)c(Cl)c3)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 3/20 0.39
▸ YTHDC1 Q96MU7 1/20 0.38
▸ CSNK2A1 P68400 3/20 0.38
▸ PAK1 Q13153 3/20 0.38
▸ PRKAB2 O43741 1/20 0.37
▸ PRKAG1 P54619 1/20 0.37
▸ PRKAA2 P54646 1/20 0.37
▸ PRKAA1 Q13131 1/20 0.37
▸ PRKAG3 Q9UGI9 1/20 0.37
▸ PRKAG2 Q9UGJ0 1/20 0.37
▸ PRKAB1 Q9Y478 1/20 0.37
▸ HRH1 P35367 2/20 0.34
▸ CCR3 P51677 2/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ IDO1 P14902 1/20 0.34
▸ CDK2 P24941 2/20 0.33
▸ LGALS8 O00214 1/20 0.33
▸ LGALS3 P17931 1/20 0.33
▸ APEX1 P27695 1/20 0.33
▸ FLT3 P36888 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4008006 0.86 YTHDC1 (0.45) NTRK1YTHDC1CSNK2A1PAK1PRKAB2
SCHEMBL4008733 0.83 APEX1 (0.46) NTRK1CSNK2A1PAK1PRKAB2PRKAG1
SCHEMBL4005400 0.82 APEX1 (0.46) NTRK1YTHDC1CSNK2A1PAK1PRKAB2
SCHEMBL4008356 0.81 YTHDC1 (0.53) NTRK1YTHDC1CSNK2A1PAK1PRKAB2
SCHEMBL4008113 0.80 APEX1 (0.49) NTRK1CSNK2A1PAK1PRKAB2PRKAG1
SCHEMBL4008425 0.79 PRKAG1 (0.40) NTRK1CSNK2A1PRKAG1PRKAA1PRKAB1
SCHEMBL4009508 0.78 NTRK1 (0.51) NTRK1YTHDC1CSNK2A1PAK1PRKAA1
SCHEMBL4014969 0.77 FLT3 (0.51) CSNK2A1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL6554266 0.77 CSNK2A1 (0.45) NTRK1CSNK2A1PRKAA1CDK2FLT3
SCHEMBL6554271 0.77 CSNK2A1 (0.45) NTRK1CSNK2A1PRKAA1CDK2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487803-A1 INDAZOLES SUBSTITUTED WITH AN ANTI-CANCEROUS ACTIVITY Aventis Pharma S.A. (FR) 2004-12-22 — — EP disclosed
WO-2003078402-A1 INDAZOLES SUBSTITUTED WITH AN ANTI-CANCEROUS ACTIVITY AVENTIS PHARMA S.A. (FR) 2003-09-25 — — WO disclosed
Send feedback